huIM-13

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamehuIM-13

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanizedDiagnostic agent (In vivo)

Mechanisms of ActionNerve growth factor receptor Trk-A modulators

TargetsNerve growth factor receptor Trk-A

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesLay Line Genomics

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesLay Line Genomics

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A